Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) Financial Metrics & Key Ratios
💡 AI Analyst Insight
The current ratio below 1.0x warrants monitoring of short-term liquidity.
RAJAF Profit Margin, ROE & Profitability Analysis
RAJAF vs Materials Sector: How Cordyceps Sunshine Biotech Holdings Co., Ltd. Compares
How Cordyceps Sunshine Biotech Holdings Co., Ltd. compares to Materials sector averages
Sector benchmarks are approximate industry averages. Actual sector performance may vary.
Is Cordyceps Sunshine Biotech Holdings Co., Ltd. Stock Overvalued? RAJAF Valuation Analysis 2026
Based on fundamental analysis, Cordyceps Sunshine Biotech Holdings Co., Ltd. has mixed fundamental signals relative to the Materials sector in 2026.
Note: This is a fundamental analysis based on SEC filings. For P/E ratio, price targets, and market-based valuation, consult financial data providers. This is not investment advice.
Cordyceps Sunshine Biotech Holdings Co., Ltd. Balance Sheet: RAJAF Debt, Cash & Liquidity
RAJAF Revenue Growth, EPS Growth & YoY Performance
RAJAF SEC Filings: Latest 10-K & 10-Q Analysis
Access official SEC EDGAR filings for Cordyceps Sunshine Biotech Holdings Co., Ltd. (CIK: 0001885680)
❓ Frequently Asked Questions about RAJAF
What is the AI rating for RAJAF?
Cordyceps Sunshine Biotech Holdings Co., Ltd. (RAJAF) has an AI grade of N/A with 0% confidence, based on fundamental analysis of SEC EDGAR filings.
What are RAJAF's key strengths?
Claude: Analysis in progress.
What are the risks of investing in RAJAF?
Claude: Analysis in progress.
What is RAJAF's revenue and growth?
Cordyceps Sunshine Biotech Holdings Co., Ltd. reported revenue of N/A.
Does RAJAF pay dividends?
Cordyceps Sunshine Biotech Holdings Co., Ltd. does not currently pay dividends.
Where can I find RAJAF SEC filings?
Official SEC filings for Cordyceps Sunshine Biotech Holdings Co., Ltd. (CIK: 0001885680) including 10-K, 10-Q, and 8-K reports are available on SEC EDGAR.
What is RAJAF's EPS?
Cordyceps Sunshine Biotech Holdings Co., Ltd. has a diluted EPS of $0.00.
How is the AI analysis conducted?
Two independent AI systems — Claude (Anthropic) and ChatGPT (OpenAI) — analyze SEC EDGAR filings including 10-K annual reports and 10-Q quarterly reports. Each AI evaluates financial health, profitability ratios, balance sheet strength, and growth metrics. The combined grade reflects both perspectives for balanced insights.
What is RAJAF's fundamental grade?
Based on our AI fundamental analysis in May 2026, Cordyceps Sunshine Biotech Holdings Co., Ltd. has a N/A grade with 0% confidence. Review the strengths and risks sections above for full context. This is not investment advice.
Is RAJAF stock overvalued or undervalued?
Valuation metrics for RAJAF: ROE of N/A (sector avg: 14%), net margin of N/A (sector avg: 10%). Compare these metrics with sector averages to assess valuation.
What is RAJAF's AI grade for 2026?
Our dual AI analysis gives Cordyceps Sunshine Biotech Holdings Co., Ltd. a combined N/A grade for 2026. Revenue is data pending, with profitability at or below sector average. Always conduct your own research.
What is RAJAF's free cash flow?
Cordyceps Sunshine Biotech Holdings Co., Ltd.'s operating cash flow is N/A, with capital expenditures of N/A.
How does RAJAF compare to other Materials stocks?
Vs Materials sector averages: Net margin N/A (avg: 10%), ROE N/A (avg: 14%), current ratio N/A (avg: 1.6).